Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis

CONCLUSION: Overall, OI treatment did not increase the risk of IOC and BOT in most women, regardless of OI drug type and OI cycle. However, nulliparous women treated with OI showed a higher risk of ovarian cancer, necessitating their rigorous monitoring and ongoing follow-up.PMID:36694251 | DOI:10.1186/s13048-022-01084-z

Source: Cancer Control - January 24, 2023 Category: Cancer & Oncology Authors: Liang Yu Jiafan Sun Qiqin Wang Wennian Yu Anqi Wang Shu Zhu Wei Xu Xiuli Wang Source Type: research